vs

Side-by-side financial comparison of AMTECH SYSTEMS INC (ASYS) and Community Healthcare Trust Inc (CHCT). Click either name above to swap in a different company.

Community Healthcare Trust Inc is the larger business by last-quarter revenue ($30.9M vs $19.0M, roughly 1.6× AMTECH SYSTEMS INC). Community Healthcare Trust Inc runs the higher net margin — 46.6% vs 0.6%, a 46.1% gap on every dollar of revenue. On growth, Community Healthcare Trust Inc posted the faster year-over-year revenue change (5.6% vs -22.2%). Community Healthcare Trust Inc produced more free cash flow last quarter ($35.9M vs $3.8M). Over the past eight quarters, Community Healthcare Trust Inc's revenue compounded faster (2.7% CAGR vs -13.6%).

Amtech Systems Inc is a global manufacturer of advanced thermal processing and automation equipment primarily serving the semiconductor, solar photovoltaic, and LED production sectors. Its product portfolio includes soldering, diffusion, and deposition systems, with key markets spanning North America, East Asia, and Western Europe, catering to leading electronic component and clean energy manufacturing clients.

Medical Properties Trust, Inc. (MPT) is an international real estate investment trust (REIT) based in Birmingham, Alabama that purchases and invests in healthcare facilities and for-profit healthcare holding companies, primarily in the United States and Europe. Their property acquisitions often come in the form of sale-leaseback agreements, in which the original property owner sells the property to MPT and becomes their tenant. MPT's tenants are generally subject to long-term triple net lease...

ASYS vs CHCT — Head-to-Head

Bigger by revenue
CHCT
CHCT
1.6× larger
CHCT
$30.9M
$19.0M
ASYS
Growing faster (revenue YoY)
CHCT
CHCT
+27.8% gap
CHCT
5.6%
-22.2%
ASYS
Higher net margin
CHCT
CHCT
46.1% more per $
CHCT
46.6%
0.6%
ASYS
More free cash flow
CHCT
CHCT
$32.1M more FCF
CHCT
$35.9M
$3.8M
ASYS
Faster 2-yr revenue CAGR
CHCT
CHCT
Annualised
CHCT
2.7%
-13.6%
ASYS

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
ASYS
ASYS
CHCT
CHCT
Revenue
$19.0M
$30.9M
Net Profit
$108.0K
$14.4M
Gross Margin
44.8%
Operating Margin
4.1%
Net Margin
0.6%
46.6%
Revenue YoY
-22.2%
5.6%
Net Profit YoY
-65.4%
687.6%
EPS (diluted)
$0.01
$0.52

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASYS
ASYS
CHCT
CHCT
Q4 25
$19.0M
$30.9M
Q3 25
$19.8M
$31.1M
Q2 25
$19.6M
$29.1M
Q1 25
$15.6M
$30.1M
Q4 24
$24.4M
$29.3M
Q3 24
$24.1M
$29.6M
Q2 24
$26.7M
$27.5M
Q1 24
$25.4M
$29.3M
Net Profit
ASYS
ASYS
CHCT
CHCT
Q4 25
$108.0K
$14.4M
Q3 25
$1.1M
$1.6M
Q2 25
$106.0K
$-12.6M
Q1 25
$-31.8M
$1.6M
Q4 24
$312.0K
$1.8M
Q3 24
$-536.0K
$1.7M
Q2 24
$438.0K
$-10.4M
Q1 24
$970.0K
$3.7M
Gross Margin
ASYS
ASYS
CHCT
CHCT
Q4 25
44.8%
Q3 25
44.4%
Q2 25
46.7%
Q1 25
-2.1%
Q4 24
38.4%
Q3 24
40.7%
Q2 24
36.5%
Q1 24
33.2%
Operating Margin
ASYS
ASYS
CHCT
CHCT
Q4 25
4.1%
Q3 25
9.3%
Q2 25
4.7%
Q1 25
-202.7%
Q4 24
1.4%
Q3 24
0.1%
Q2 24
3.1%
Q1 24
5.4%
Net Margin
ASYS
ASYS
CHCT
CHCT
Q4 25
0.6%
46.6%
Q3 25
5.4%
5.3%
Q2 25
0.5%
-43.2%
Q1 25
-204.2%
5.3%
Q4 24
1.3%
6.3%
Q3 24
-2.2%
5.9%
Q2 24
1.6%
-37.9%
Q1 24
3.8%
12.5%
EPS (diluted)
ASYS
ASYS
CHCT
CHCT
Q4 25
$0.01
$0.52
Q3 25
$0.08
$0.03
Q2 25
$0.01
$-0.50
Q1 25
$-2.23
$0.03
Q4 24
$0.02
$0.04
Q3 24
$-0.04
$0.04
Q2 24
$0.03
$-0.42
Q1 24
$0.07
$0.11

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASYS
ASYS
CHCT
CHCT
Cash + ST InvestmentsLiquidity on hand
$22.1M
$3.3M
Total DebtLower is stronger
$162.0K
$532.2M
Stockholders' EquityBook value
$54.1M
$429.4M
Total Assets
$94.1M
$990.8M
Debt / EquityLower = less leverage
0.00×
1.24×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASYS
ASYS
CHCT
CHCT
Q4 25
$22.1M
$3.3M
Q3 25
$17.9M
$3.4M
Q2 25
$15.6M
$4.9M
Q1 25
$13.4M
$2.3M
Q4 24
$13.2M
$4.4M
Q3 24
$11.1M
$2.8M
Q2 24
$13.2M
$734.0K
Q1 24
$13.0M
$3.8M
Total Debt
ASYS
ASYS
CHCT
CHCT
Q4 25
$162.0K
$532.2M
Q3 25
$168.0K
$530.1M
Q2 25
$127.0K
$500.1M
Q1 25
$135.0K
$496.0M
Q4 24
$161.0K
$486.0M
Q3 24
$189.0K
$473.7M
Q2 24
$177.0K
$457.6M
Q1 24
$65.0K
$442.3M
Stockholders' Equity
ASYS
ASYS
CHCT
CHCT
Q4 25
$54.1M
$429.4M
Q3 25
$53.4M
$426.8M
Q2 25
$51.7M
$437.8M
Q1 25
$51.0M
$461.3M
Q4 24
$82.4M
$476.0M
Q3 24
$82.4M
$477.2M
Q2 24
$81.7M
$497.8M
Q1 24
$80.9M
$511.6M
Total Assets
ASYS
ASYS
CHCT
CHCT
Q4 25
$94.1M
$990.8M
Q3 25
$92.9M
$987.3M
Q2 25
$89.5M
$966.3M
Q1 25
$83.4M
$985.1M
Q4 24
$117.8M
$992.6M
Q3 24
$119.3M
$981.8M
Q2 24
$127.1M
$983.2M
Q1 24
$116.5M
$982.7M
Debt / Equity
ASYS
ASYS
CHCT
CHCT
Q4 25
0.00×
1.24×
Q3 25
0.00×
1.24×
Q2 25
0.00×
1.14×
Q1 25
0.00×
1.08×
Q4 24
0.00×
1.02×
Q3 24
0.00×
0.99×
Q2 24
0.00×
0.92×
Q1 24
0.00×
0.86×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASYS
ASYS
CHCT
CHCT
Operating Cash FlowLast quarter
$4.1M
$56.4M
Free Cash FlowOCF − Capex
$3.8M
$35.9M
FCF MarginFCF / Revenue
20.2%
116.0%
Capex IntensityCapex / Revenue
1.5%
66.3%
Cash ConversionOCF / Net Profit
37.99×
3.91×
TTM Free Cash FlowTrailing 4 quarters
$8.0M
$62.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASYS
ASYS
CHCT
CHCT
Q4 25
$4.1M
$56.4M
Q3 25
$2.3M
$12.7M
Q2 25
$2.5M
$13.8M
Q1 25
$210.0K
$14.4M
Q4 24
$2.9M
$58.9M
Q3 24
$879.0K
$13.8M
Q2 24
$3.7M
$16.7M
Q1 24
$336.0K
$12.6M
Free Cash Flow
ASYS
ASYS
CHCT
CHCT
Q4 25
$3.8M
$35.9M
Q3 25
$2.0M
$7.6M
Q2 25
$2.0M
$9.6M
Q1 25
$201.0K
$9.7M
Q4 24
$2.7M
$34.2M
Q3 24
$447.0K
$6.7M
Q2 24
$322.0K
$9.5M
Q1 24
$-884.0K
$7.5M
FCF Margin
ASYS
ASYS
CHCT
CHCT
Q4 25
20.2%
116.0%
Q3 25
10.2%
24.6%
Q2 25
10.1%
32.9%
Q1 25
1.3%
32.3%
Q4 24
11.2%
116.9%
Q3 24
1.9%
22.5%
Q2 24
1.2%
34.7%
Q1 24
-3.5%
25.7%
Capex Intensity
ASYS
ASYS
CHCT
CHCT
Q4 25
1.5%
66.3%
Q3 25
1.2%
16.3%
Q2 25
2.8%
14.5%
Q1 25
0.1%
15.6%
Q4 24
0.6%
84.1%
Q3 24
1.8%
24.2%
Q2 24
12.5%
26.1%
Q1 24
4.8%
17.4%
Cash Conversion
ASYS
ASYS
CHCT
CHCT
Q4 25
37.99×
3.91×
Q3 25
2.12×
7.76×
Q2 25
23.89×
Q1 25
9.06×
Q4 24
9.19×
32.14×
Q3 24
7.92×
Q2 24
8.35×
Q1 24
0.35×
3.45×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ASYS
ASYS

Thermal Processing Solutions$14.0M74%
Semiconductor Fabrication Solutions$5.0M26%

CHCT
CHCT

Segment breakdown not available.

Related Comparisons